Advances and highlights in asthma in 2021

Last year brought a significant advance in asthma management, unyielding to the pressure of the pandemics. Novel key findings in asthma pathogenesis focus on the resident cell compartment, epigenetics and the innate immune system. The precision immunology unbiased approach was supplemented with nove...

Full description

Saved in:
Bibliographic Details
Published in:Allergy (Copenhagen) 2021-11, Vol.76 (11), p.3390-3407
Main Authors: Agache, Ioana, Eguiluz‐Gracia, Ibon, Cojanu, Catalina, Laculiceanu, Alexandru, Giacco, Stefano, Zemelka‐Wiacek, Magdalena, Kosowska, Anna, Akdis, Cezmi A., Jutel, Marek
Format: Article
Language:English
Subjects:
Artificial intelligence
Asthma
biomarkers
Clinical trials
endotypes
Epigenetics
exacerbations
guidelines
Immune system
Innate immunity
Pandemics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Last year brought a significant advance in asthma management, unyielding to the pressure of the pandemics. Novel key findings in asthma pathogenesis focus on the resident cell compartment, epigenetics and the innate immune system. The precision immunology unbiased approach was supplemented with novel tools and greatly facilitated by the use of artificial intelligence. Several randomised clinical trials and good quality real‐world evidence shed new light on asthma treatment and supported the revision of several asthma guidelines (GINA, Expert Panel Report 3, ERS/ATS guidelines on severe asthma) and the conception of new ones (EAACI Guidelines for the use of biologicals in severe asthma). Integrating asthma management within the broader context of Planetary Health has been put forward. In this review, recently published articles and clinical trials are summarised and discussed with the goal to provide clinicians and researchers with a concise update on asthma research from a translational perspective.
ISSN:0105-4538
1398-9995
DOI:10.1111/all.15054